The Chemours Aktie
11,84
EUR
-0,41
EUR
-3,31
%
14,00
USD
-0,63
USD
-4,31
%
Werbung
The Chemours Aktie Analyse
29.03.18 | The Chemours Outperform | BMO Capital Markets | |
07.08.17 | The Chemours Neutral | UBS AG | |
09.05.16 | The Chemours overweight | Barclays Capital | |
18.09.15 | The Chemours Hold | Argus Research Company | |
18.08.15 | The Chemours Sell | UBS AG |
Werbung
Werbung